Samjin Pharmaceutical Changes Largest Shareholder to Hana Pharmaceutical and Three Others
[Asia Economy Reporter Han Jinju] Samjin Pharmaceutical announced on the 27th that the largest shareholder has changed to Hana Pharmaceutical and three others (Jo Yerim, Jo Hyerim, Jo Donghun) through off-hours trading involving a change in the largest shareholder. The largest shareholder side stated that the purpose of acquiring the shares is "simple investment."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- The "90% Reality" Dominating Teens: Experts Shocked by Record-High Figures, Calling It "Just the Tip of the Iceberg" [Chuiyakgukga]⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Bought for a Special Price, but Cheaper Today"... Online Malls Caught Inflating Discount Rates by Raising Regular Prices
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Hana Pharmaceutical secured 50,000 shares through off-hours trading, increasing its holdings to 1,819,472 shares. The shareholding ratio of Hana Pharmaceutical and the three others changed from 12.73% to 13.09%.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.